Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy / LiveScience

livescience - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #infanthealth

Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy

11 days / livescience

Drug breakthrough for children with severe form of epilepsy

12 days / bbc

First gene regulation clinical trials for epilepsy show promising results

12 days / medicalxpress

Life-changing drug identified for children with rare epilepsy

12 days / medicalxpress

Thursday, March 5, 2026, 4:23 pm / permalink 20233 / 4 stories in 11 days

Related Stories

Pediatricians’ immune cells yield antibody cocktail protecting against RSV and hMPV / 25 days
FDA Lifts Hold on Intellia’s Phase 3 Gene Editing Trial / 6 wks
FDA rejects Corcept’s cortisol modulator triggering setback / 2 months
FDA approves Rucaparib for advanced prostate cancer / 2 months
FDA approves first gene therapy for Wiskott‐Aldrich syndrome / 3 months
FDA Approves Novartis’ Itvisma Gene Therapy for SMA Across Age Groups / 3 months
FDA Approves Ziftomenib for AML Treatment / 3 months

Related Tags

Healthcare

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (16 hrs)

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

more #healthcare

Pharmaceuticals

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (20 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

more #pharmaceuticals

Public Health

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

AI improves UK breast-screening detection by about 10% (2 days)

more #publichealth

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.